Related Experiment Video
Updated: May 22, 2025

Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
Role of Continuous Glucose Monitoring in Supporting Glycemic Control Among Adolescents with Type 1 Diabetes in Saudi
Norah A Alshehri1,2, Maha Saud Alessa3, Abdullah A Alrasheed1,2
1Department of Family and Community Medicine, College of Medicine, King Saud University (KSU), Riyadh 11362, Saudi Arabia.
Abstract:
Background/Objectives: Continuous glucose monitoring (CGM) has emerged as an important tool for the improvement of glycemic control in individuals with type 1 diabetes (T1D). However, its use has not been greatly explored among adolescents with special physiological and psychosocial challenges. This study evaluated the role of CGM in supporting glycemic control among high-risk adolescents with T1D in Saudi Arabia. Methods: This retrospective observational study was conducted among 73 adolescents aged 12-19 with T1D and baseline HbA1c ≥ 9% treated at King Khalid University Hospital in Riyadh, Saudi Arabia. Data were extracted from electronic health records over a three-month period. The HbA1c levels before and after CGM use were analyzed using paired t-tests. In addition, analyses included studying the correlations and regression models and assessing associations between changes in HbA1c and patient characteristics. Results: Mean HbA1c was significantly reduced from 9.48 ± 2.22% to 9.06 ± 1.91% following three months of CGM, with an average decrease of -0.42 ± 1.37%, p = 0.011. Changes in HbA1c did not correlate with various patient factors of interest: age, gender, body mass index, disease duration, and insulin type. Within a specified timeframe, 54.8% of patients reported hypoglycemia, and 38.4% reported diabetic ketoacidosis. Conclusions: CGM resulted in a small but statistically significant improvement in glycemic control in adolescents with T1D. Given such results, these findings highlight the need for larger, long-term trials to optimize CGM use in this vulnerable population, particularly through integrating advanced features (e.g., predictive alarms) and structured education programs to reduce hypoglycemia and DKA risks. Effective integration of CGM in daily diabetes management may lead to better long-term clinical outcomes and improved quality of life for adolescents.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

